IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

120 hedge funds and large institutions have $404M invested in iShares US Pharmaceuticals ETF in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 9 closing their positions.

Holders
120
Holders Change
+9
Holders Change %
+8.11%
% of All Funds
3.24%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
19
Increased
45
Reduced
35
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RJA
1
Raymond James & Associates
Florida
$13.6M
2
Citadel Advisors
2
Citadel Advisors
Florida
$4.3M
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$19.7M
4
UFF
4
USA Financial Formulas
Michigan
$3.99M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$2.65M

Top Sellers

1
Bank of Montreal
1
Bank of Montreal
Ontario, Canada
$1.17M
2
BHB
2
Bank Hapoalim BM
Israel
$271K
3
RJFSA
3
Raymond James Financial Services Advisors
Florida
$0
4
AWA
4
ARS Wealth Advisors
Florida
$18.6M
5
SG Americas Securities
5
SG Americas Securities
New York
$235K
Name Holding Trade Value Shares
Change 		Shares
Change %
IP
126
Investment Partners
Ohio
– -$13K -225 Closed
MPWT
127
MassMutual Private Wealth & Trust
Connecticut
– -$7.59K -132 Closed
CCS
128
Crosspoint Capital Strategies
California
– -$2K -33 Closed
2 3 4 5
6